Technical Analysis for VRPX - Virpax Pharmaceuticals, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
MACD Bearish Signal Line Cross | Bearish | 0.00% | |
20 DMA Support | Bullish | 0.00% | |
Calm After Storm | Range Contraction | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Gapped Down | Weakness | 0.00% | |
20 DMA Support | Bullish | -10.53% | |
50 DMA Support | Bullish | -10.53% | |
Wide Bands | Range Expansion | -10.53% | |
50 DMA Support | Bullish | -3.62% |
Alert | Time |
---|---|
20 DMA Support | about 11 hours ago |
Down 1 ATR | about 11 hours ago |
Possible NR7 | about 12 hours ago |
Possible Inside Day | about 12 hours ago |
60 Minute Opening Range Breakdown | about 15 hours ago |
Get a Trading Assistant
- Earnings date: 03/28/2024
Virpax Pharmaceuticals, Inc. Description
Virpax Pharmaceuticals, Inc. develops and manufactures non-opioid and non-addictive based drug compounds and drug delivery systems for pain management. It offers products, such as Probudur, an injectable bupivacaine hydrogel for postoperative pain management; Epoladerm, a diclofenac metered-dose spray film for acute musculoskeletal pain; and NES100, an endogenous enkephalin intranasal spray for acute and chronic spray. The company develops drug delivery technologies, such as Topical metered-dose spray, Liposomal in Hydrogel encapsulation, and Enkephalin Intranasal spray. It also develops therapies to manage post-traumatic stress disorder (PTSD), as well as to help prevent viral spread, including influenza and SARS-CoV-2 (Covid-19). Virpax Pharmaceuticals, Inc. was founded in 2016 and is based in Malvern, Pennsylvania.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Sciences Drugs Pain Euphoriants Opioids Influenza Pain Management Drug Delivery Analgesics Morphinans Post Traumatic Stress Disorder Drug Delivery Systems Heroin Bupivacaine Morphine Nasal Administration
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 11.774 |
52 Week Low | 2.402 |
Average Volume | 23,903 |
200-Day Moving Average | 6.58 |
50-Day Moving Average | 3.45 |
20-Day Moving Average | 3.66 |
10-Day Moving Average | 4.13 |
Average True Range | 0.56 |
RSI (14) | 51.22 |
ADX | 39.66 |
+DI | 29.12 |
-DI | 16.58 |
Chandelier Exit (Long, 3 ATRs) | 3.81 |
Chandelier Exit (Short, 3 ATRs) | 4.37 |
Upper Bollinger Bands | 4.83 |
Lower Bollinger Band | 2.50 |
Percent B (%b) | 0.53 |
BandWidth | 63.39 |
MACD Line | 0.16 |
MACD Signal Line | 0.16 |
MACD Histogram | -0.0018 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 4.37 | ||||
Resistance 3 (R3) | 4.38 | 4.17 | 4.26 | ||
Resistance 2 (R2) | 4.17 | 4.00 | 4.16 | 4.23 | |
Resistance 1 (R1) | 3.95 | 3.90 | 3.85 | 3.94 | 4.19 |
Pivot Point | 3.74 | 3.74 | 3.69 | 3.74 | 3.74 |
Support 1 (S1) | 3.52 | 3.58 | 3.42 | 3.52 | 3.27 |
Support 2 (S2) | 3.31 | 3.48 | 3.31 | 3.23 | |
Support 3 (S3) | 3.10 | 3.31 | 3.20 | ||
Support 4 (S4) | 3.09 |